<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02193035</url>
  </required_header>
  <id_info>
    <org_study_id>31446114.1.0000.0068</org_study_id>
    <nct_id>NCT02193035</nct_id>
  </id_info>
  <brief_title>Microparticles in Severe Aortic Stenosis</brief_title>
  <official_title>Microparticles as an Inflammatory Marker in Severe Aortic Stenosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InCor Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InCor Heart Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Microparticles are small cell fragments that can induce fat plaques, calcification and
      formation of thrombus. They can be released through multiple stimulations, but also the high
      flow of blood through partially obstructed aortic valves.

      In patients with severely obstructed aortic valves the investigators hypothesize that
      microparticles levels will be elevated and that they will go down after percutaneous
      treatment of the valves.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microparticle (MPs) levels and subtypes according to endothelial cell, macrophage and
      platelet markers will be measured by flow-cytometry using appropriate fluorochromes. Patient
      baseline (including measures of severity of aortic stenosis and its calcification),
      procedural data, and clinical evolution will be collected. Inflammatory markers will be
      measured, which along with clinical date will be tested for correlation with microparticle
      levels.

      Patients MPs will be measured before and after percutaneous treatment of the severe aortic
      stenosis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in microparticle levels</measure>
    <time_frame>Day 5</time_frame>
    <description>Difference of total microparticle levels before and after treatment of patients with percutaneous aortic valve replacement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial microparticle levels</measure>
    <time_frame>Day 5</time_frame>
    <description>Difference of endothelial microparticle levels before and after treatment of patients with percutaneous aortic valve replacement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Macrophage microparticle levels</measure>
    <time_frame>Day 5</time_frame>
    <description>Difference of macrophage microparticle levels before and after treatment of patients with percutaneous aortic valve replacement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet microparticle levels</measure>
    <time_frame>Day 5</time_frame>
    <description>Difference of platelet microparticle levels before and after treatment of patients with percutaneous aortic valve replacement</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Single group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with severe aortic stenosis treated with transcatheter aortic valve replacement (TAVR). Microparticle levels will be measured before and after TAVR.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Microparticle levels</intervention_name>
    <description>Microparticle levels will be evaluated with flow cytometry and nanoparticle tracking analysis</description>
    <arm_group_label>Single group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical indication to be treated with transcatheter aortic valve replacement.

        Exclusion Criteria:

          -  Non native aortic valve

          -  Moderate aortic regurgitation

          -  The following complications following valve implantation: patient instability, need
             for vasoactive pressors, sepsis and severe infections, stroke.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pedro Lemos, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Institute - InCor. University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julio F Marchini, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Institute - InCor. University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Institute - InCor. University of Sao Paulo Medical School</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Marchini JF, Miyakawa AA, Tarasoutchi F, Krieger JE, Lemos P, Croce K. Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement. J Negat Results Biomed. 2016 Apr 11;15:7. doi: 10.1186/s12952-016-0051-2.</citation>
    <PMID>27063005</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2014</study_first_submitted>
  <study_first_submitted_qc>July 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2014</study_first_posted>
  <last_update_submitted>April 12, 2016</last_update_submitted>
  <last_update_submitted_qc>April 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>InCor Heart Institute</investigator_affiliation>
    <investigator_full_name>Pedro A. Lemos</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Microparticles</keyword>
  <keyword>Severe aortic stenosis</keyword>
  <keyword>Calcified aortic stenosis</keyword>
  <keyword>transcatheter aortic valve replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

